A compound of specific bioactive products from a major family of enzymes reduced the severity of age-related macular degeneration (AMD) in a preclinical model, according to a study led by Massachusetts Eye and Ear researchers and published online August 21st 2017 in the Proceedings of the National Academy of Sciences. A release from Massachusetts Eye… Continue reading Key Compounds to Resolve Abnormal Vascular Growth in AMD Have Been Identified